Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Frankfurt - Delayed Quote • EUR Abeona Therapeutics Inc. (PCJ.F) Follow Compare 4.8400 -0.0800 (-1.63%) At close: February 28 at 8:07:15 AM GMT+1 Comparisons Indicators Technicals Corporate Events Line Candle Baseline Mountain Bar Step Baseline Delta HLC Wave Scatterplot Histogram Range Channel Colored Line Colored Mountain Colored Step Colored Bar Colored HLC Volume Candle Hollow Candle Step Mountain Verex Line Vertex Step Vertex Mountain Vertex Baseline Delta Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for PCJ.F 1D 5D -11.19% 1M -2.02% 3M -18.66% 6M -4.16% YTD -7.81% 1Y -26.83% 5Y -35.47% All -95.88% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours 1 day 1 week 1 month 3 months Recent News: PCJ.F View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Abeona Therapeutics Inc.'s (NASDAQ:ABEO) Shift From Loss To Profit Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Owning 43% shares,institutional owners seem interested in Abeona Therapeutics Inc. (NASDAQ:ABEO), DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025 ABEO: FDA Accepts BLA Re-Submission for Pz-cel; PDUFA Date of April 29, 2025; Raising Valuation to $9.50… Abeona Therapeutics Inc (ABEO) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... Abeona Therapeutics: Q3 Earnings Snapshot Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa Abeona Therapeutics® Announces Participation in November Investor Conferences Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration Related Tickers ARDX.MX Ardelyx, Inc. 105.50 0.00% 41X.SG Ardelyx Inc 4.9440 -1.71% NKTR Nektar Therapeutics 0.8400 +5.50% LXRX Lexicon Pharmaceuticals, Inc. 0.6995 +4.40%